Bringing clinical trials to previously underrepresented communities requires showcasing trustworthiness. Goldie Smith Byrd, PhD, Director, Maya Angelou Center for Health Equity (MACHE) at the Wake Forest School of Medicine, shares how she has approached building trust and her advice for pharma on successful community engagement.
